This excerpt taken from the ACL 6-K filed Feb 4, 2008.
Report) for each quarter other than the quarter ending December 31, (iv) the furnishing of each Report to the United States Securities and Exchange Commission and all exchanges on which the Company's securities are listed to the extent required by the rules of such exchanges, in each case in the form approved by the Audit Committee; and
(q) to review and reassess the adequacy of the Audit Committee provisions of these Organizational Regulations annually and submit any proposals for revision to the Board for approval.
In discharging its oversight responsibilities, the Audit Committee shall have unrestricted access to the Company's management, books and records.
The Audit Committee shall meet at least four times per year. It shall regularly report to the Board on its findings and propose the appropriate actions. The ultimate responsibility for approving the annual and quarterly financial statements will remain with the Board.
Section 4. Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee shall be comprised of four members of the Board, as determined from time to time by the Board. Two Committee members shall be chosen from among the independent Directors as defined under the NYSE Rules; in addition, two Committee members shall be designated by the Majority Shareholder, inclusive of the Vice-Chairman of the Board. The Nominating and Corporate Governance Committee shall operate under and in accordance with a committee charter adopted by the Board.
The members of the Nominating and Corporate Governance Committee shall be appointed by the full Board for a one year term. Members of the Committee shall be eligible for re-election. The chairperson of the Committee shall be designated by the Board.
The Nominating and Corporate Governance Committee shall have the following powers and duties:
(a) Determination of the criteria, objectives and procedures for selecting members of the Board;
(b) Search and review of potential candidates qualified to become members of the Board, and recommendation of such individuals to the full Board for a nomination for election by the shareholders;
(d) Recommendation to the Board as to the class of directors on which a new director shall serve;
(f) Review of appropriateness of continued service on the Board of members whose circumstances (including business or professional affiliations or responsibilities) have changed or who contemplate accepting a directorship on another public company board or an appointment to an audit or compensation committee of another public company board;
(g) Recommendation to the Board for the appointment of the members of the Executive Management, upon motion of the CEO;
(h) Oversight of the Company's orientation process for newly elected members of the board, and assistance of the board in its implementation; assessment of the adequacy of and need for additional continuing director education programs;
(i) Development of corporate governance guidelines for the Company, assessment of those guidelines at least on an annual basis;
(j) Oversight of the system and procedures for the education, development and orderly succession of senior members throughout the Group, including, at least annually, review of the CEO's short- and long-term succession plans for the CEO and other senior management positions;
(l) Review of its own performance and reassessment of the adequacy of its rules of procedures.
In discharging its functions, the Nominating and Corporate Governance Committee shall have the authority to retain and terminate any search firm to be used to identify candidates for the position of Board member or member of Executive Management. The Committee may further obtain, at the expense of the Company, advice and assistance from internal or external legal, accounting or other advisors as it deems advisable without having to seek Board approval. The Committee shall finally have the authority to conduct or authorize investigations into or studies of any matters within the Committee's scope of responsibilities.
The Nominating and Corporate Governance Committee shall meet at least four times per year. It may request that any directors, officers or other employees of the Company, or any other person whose advice is sought by the Committee, attend any Committee meetings to provide such information as the Committee requests. The Committee shall take minutes of its meetings, and shall regularly report to the Board on its findings and propose the appropriate actions.
Except as set forth in this Article V, Section 4 or in any resolution of the Board of Directors, the Nominating and Corporate Governance Committee shall set its own rules of procedure.
Section 5. Independent Director Committee. If any of the following transactions is proposed to be taken by the Company, the Board shall form a special committee of no less than three independent directors as defined under the NYSE Rules who shall be responsible for protecting the interests of the minority shareholders of the Company. The Board shall only resolve such matters if a majority of the members of Independent Director Committee so recommends. Such matters are
(a) a proposed merger, takeover, business combination or related party transaction of the Company with the Majority Shareholder or any group company of the Majority Shareholder;
(b) a proposed bid for the shares of the Company by any entity owning a majority of the Company's outstanding voting rights;
(c) a proposed repurchase by the Company of all the shares not owned by an entity owning a majority of the outstanding voting rights of the Company; or
Section 6. Committee Procedures. Each of the Board Committees shall establish its own terms of reference which shall, to the extent necessary or expedient, comply with the provisions of the NYSE Rules.
Board Committees shall meet at the place of incorporation of the Company or at another place as determined by the chairman of the Board Committee.
Section 7. Research and Development and Scientific Advisory Board. The Board may appoint a research and development and scientific advisory board (the